Astellas, Pfizer Settle Patent Suit Over Sun’s Copies of Xtandi

Astellas Pharma Inc. and Pfizer Inc. have settled their lawsuit with Sun Pharmaceutical Industries Ltd. over copies of the multibillion-dollar prostate cancer drug Xtandi, court filings show.

The co-plaintiffs and Sun agreed to drop all claims regarding US Patent No. 7,709,517, but they left the door open to renew their respective allegations, according to their proposed dismissal order filed Oct. 20 in the US District Court for the District of New Jersey.

The deal hasn’t yet been approved, but Magistrate Judge Jessica S. Allen earlier this week granted the parties’ request to unseal their joint status update filed Sept. ...